- Home
- MNOV vs FTHA Comparison
MNOV vs FTHA Comparison
Compare MNOV & FTHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MNOV | FTHA |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 137.8M | 137.6M |
| IPO Year | 2004 | 2026 |
Fundamental Metrics
Financial Performance| Metric | MNOV | FTHA |
|---|---|---|
| Price | $2.64 | $9.97 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $7.50 | N/A |
| AVG Volume (30 Days) | ★ 683.6K | 90.6K |
| Earning Date | 05-14-2026 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,360,807.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $180.00 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 194.15 | N/A |
| 52 Week Low | $1.17 | $9.85 |
| 52 Week High | $3.90 | $9.98 |
Technical Indicators
Market Signals| Indicator | MNOV | FTHA |
|---|---|---|
| Relative Strength Index (RSI) | 62.19 | 63.81 |
| Support Level | $1.28 | $9.93 |
| Resistance Level | $3.90 | $9.98 |
| Average True Range (ATR) | 0.30 | 0.01 |
| MACD | 0.04 | 0.00 |
| Stochastic Oscillator | 43.06 | 93.08 |
Price Performance
Historical ComparisonAbout MNOV Medicinova Inc
MediciNova Inc is a biopharmaceutical company developing novel therapeutics for the treatment of serious diseases with unmet medical needs and a commercial focus on the United States (U.S.) market. It is currently focused on developing MN-166 (ibudilast) for neurological and other disorders such as progressive multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and prevention of acute respiratory distress syndrome (ARDS); and MN-001 (tipelukast) for fibrotic and other metabolic disorders such as nonalcoholic fatty liver disease (NAFLD), and hypertriglyceridemia.
About FTHA Forefront Tech Holdings Acquisition Corp Class A Ordinary Shares
Forefront Tech Holdings Acquisition Corp is a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar Business Combination with one or more businesses.